News

The imaging agent called Cytalux works by having patients receive an infusion before surgery that causes cancerous cells to ...
Advanced imaging and robotic technology making lung cancer biopsy safer, more accurate at WVU Medicine MORGANTOWN — Lung cancer is the leading cause of cancer deaths worldwide, according to the ...
Short-interval CT imaging is a safe and cost-effective strategy for focal indeterminate consolidation in lung cancer ...
A newly released white paper shares four real-world cases where bioAffinity's CyPath® Lung played a pivotal role in guiding ...
A new study published in Nature Communications introduces a multimodal multitask foundation model that significantly enhances the capabilities of low-dose CT. This AI model improves the prediction of ...
Mumbai: Johnson & Johnson MedTech has onboarded Qure.ai as a strategic partner with Johnson & Johnson Private Limited, a ...
Helene Duhamel was recently diagnosed with non-small cell squamous cell lung cancer. Duhamel shares her thoughts on her ...
The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...
Following immunotherapy treatments in the last decade, new therapeutic strategies for cancer are beginning to emerge.
Johnson & Johnson MedTech, a global leader in surgical technologies and solutions, has onboarded Qure.ai, a global leader in artificial intelligence (AI) for healthcare, as a strategic partner with ...